LANDOS BIOPHARMA INC's ticker is LABP and the CUSIP is 515069102. A total of 36 filers reported holding LANDOS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24 | -61.9% | 79,201 | -36.8% | 0.00% | – |
| Q4 2022 | $63 | -100.0% | 125,401 | -51.5% | 0.00% | – |
| Q3 2022 | $168,000 | -40.6% | 258,701 | -33.5% | 0.00% | – |
| Q2 2022 | $283,000 | -43.6% | 388,732 | +14.2% | 0.00% | -100.0% |
| Q1 2022 | $502,000 | -38.9% | 340,500 | +99.0% | 0.00% | 0.0% |
| Q4 2021 | $821,000 | +416.4% | 171,100 | +1469.7% | 0.00% | – |
| Q3 2021 | $159,000 | – | 10,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 1,827,478 | $2,696,000 | 2.05% |
| Perceptive Advisors | 14,869,915 | $21,933,000 | 0.44% |
| RTW INVESTMENTS, LP | 4,275,722 | $6,307,000 | 0.13% |
| ArchPoint Investors | 128,750 | $190,000 | 0.07% |
| Orbimed Advisors | 283,217 | $418,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,000 | $235,000 | 0.01% |
| Walleye Capital LLC | 93,533 | $138,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 158,875 | $234,000 | 0.00% |
| Renaissance Technologies | 340,500 | $502,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,324 | $3,000 | 0.00% |